# Sonnet Biotherapeutics, Inc. — Form D

Sonnet Biotherapeutics, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-14. The offering totals $750K, of which $750K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-05-14
- Form: D
- Accession: 0001776263-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $750K
- Amount sold: $750K
- Investors: 7
- Date of first sale: 2019-04-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-339578

## Issuer

- Name: Sonnet Biotherapeutics, Inc.
- CIK: 0001776628
- Entity type: Corporation
- Jurisdiction: NEW JERSEY
- Incorporated: 2015
- Address: 100 OVERLOOK CENTER, PRINCETON, NJ, 08540
- Phone: 609-375-2227

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Pankaj Mohan | Director | Princeton, NJ |
| John Cini | Executive Officer | Princeton, NJ |
| Susan Dexter | Executive Officer | Ottawa, A6 |
| Donald Griffith | Executive Officer | Princeton, NJ |
| Pankaj Mohan | Executive Officer | Princeton, NJ |
| Terence Rugg | Executive Officer | Princeton, NJ |

## More

- [CIK 1776628 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1776628&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001776263-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.